Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 1,942Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 2AMCOL Health & Beauty Solutions, Inc DBA AMCOL Household and Personal Care

02 1AMCOL Health & Beauty Solutions, Inc. DBA

03 1Asclemed USA Inc.

04 1Chongqing Huapont Pharmaceutical Co Ltd

05 1DARMERICA, LLC

06 1Fagron Inc

07 1Galenova Inc

08 1Genvion Corporation

09 1KALCHEM INTERNATIONAL INC.

10 1LETCO MEDICAL, LLC

11 1Medisca Inc.

12 2Olon SpA

13 1Professional Compounding Centers of America dba PCCA

14 1Siegfried PharmaChemikalien Minden GmbH

15 1Sionc Pharmaceutical Private Limited

16 1Spectrum Laboratory Products, Inc.

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

02

Organic Process R&D
Not Confirmed
arrow
arrow
Organic Process R&D
Not Confirmed

TRETINOIN

NDC Package Code : 51552-0120

Start Marketing Date : 1998-04-01

End Marketing Date : 2025-04-15

Dosage Form (Strength) : POWDER (1g/g)

Marketing Category : BULK INGREDIENT FOR HUMAN P...

blank

03

OPRD USA
Not Confirmed
arrow
arrow
OPRD USA
Not Confirmed

TRETINOIN

NDC Package Code : 62049-003

Start Marketing Date : 2015-07-06

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1g/g)

Marketing Category : BULK INGREDIENT

blank

04

Organic Process R&D
Not Confirmed
arrow
arrow
Organic Process R&D
Not Confirmed

TRETINOIN

NDC Package Code : 60592-738

Start Marketing Date : 2023-10-13

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1g/g)

Marketing Category : BULK INGREDIENT

blank

05

Organic Process R&D
Not Confirmed
arrow
arrow
Organic Process R&D
Not Confirmed

TRETINOIN

NDC Package Code : 62991-2057

Start Marketing Date : 2011-11-28

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1g/g)

Marketing Category : BULK INGREDIENT FOR HUMAN P...

blank

06

OPRD USA
Not Confirmed
arrow
arrow
OPRD USA
Not Confirmed

TRETINOIN

NDC Package Code : 38779-0001

Start Marketing Date : 2015-07-06

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1g/g)

Marketing Category : BULK INGREDIENT FOR HUMAN P...

blank

07

Organic Process R&D
Not Confirmed
arrow

08

Organic Process R&D
Not Confirmed
arrow

09

OPRD USA
Not Confirmed
arrow
arrow
OPRD USA
Not Confirmed

TRETINOIN

NDC Package Code : 51927-1270

Start Marketing Date : 2002-07-19

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT FOR HUMAN P...

blank

10

OPRD USA
Not Confirmed
arrow
arrow
OPRD USA
Not Confirmed

TRETINOIN

NDC Package Code : 49452-6243

Start Marketing Date : 1995-03-01

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1g/g)

Marketing Category : BULK INGREDIENT

blank

Looking for 302-79-4 / Tretinoin API manufacturers, exporters & distributors?

Tretinoin manufacturers, exporters & distributors 1

60

PharmaCompass offers a list of Tretinoin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Tretinoin manufacturer or Tretinoin supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Tretinoin manufacturer or Tretinoin supplier.

PharmaCompass also assists you with knowing the Tretinoin API Price utilized in the formulation of products. Tretinoin API Price is not always fixed or binding as the Tretinoin Price is obtained through a variety of data sources. The Tretinoin Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Tretinoin

Synonyms

Retinoic acid, 302-79-4, All-trans-retinoic acid, Vitamin a acid, Trans-retinoic acid, Atra

Cas Number

302-79-4

Unique Ingredient Identifier (UNII)

5688UTC01R

About Tretinoin

An important regulator of GENE EXPRESSION during growth and development, and in NEOPLASMS. Tretinoin, also known as retinoic acid and derived from maternal VITAMIN A, is essential for normal GROWTH; and EMBRYONIC DEVELOPMENT. An excess of tretinoin can be teratogenic. It is used in the treatment of PSORIASIS; ACNE VULGARIS; and several other SKIN DISEASES. It has also been approved for use in promyelocytic leukemia (LEUKEMIA, PROMYELOCYTIC, ACUTE).

AVITA Manufacturers

A AVITA manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of AVITA, including repackagers and relabelers. The FDA regulates AVITA manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. AVITA API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of AVITA manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

AVITA Suppliers

A AVITA supplier is an individual or a company that provides AVITA active pharmaceutical ingredient (API) or AVITA finished formulations upon request. The AVITA suppliers may include AVITA API manufacturers, exporters, distributors and traders.

click here to find a list of AVITA suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

AVITA NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing AVITA as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for AVITA API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture AVITA as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain AVITA and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a AVITA NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of AVITA suppliers with NDC on PharmaCompass.

AVITA Manufacturers | Traders | Suppliers

AVITA Manufacturers, Traders, Suppliers 1
Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.